Get started
Author

Jérémie Decalf

Observed names: Decalf, Jérémie, J. Decalf, Jeremie Decalf, Jérémie Decalf
Institution: Genentech
Observed institutions: University of Lisbon, Inserm, Institut Pasteur, Genentech, Université Paris Sciences et Lettres, Immunité et Cancer, Instituto de Medicina Molecular João Lobo Antunes, Institut Curie
ORCID: 0000-0002-1113-6128
Observed ORCID: 0000-0002-1113-6128
OpenAlex ID: A5036412535
Detection of interferon alpha protein reveals differential levels and cellular sources in disease
2017 · Mathieu P. Rodero, Jérémie Decalf, et al. · The Journal of Experimental Medicine · 389
PDF
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
2010 · Armanda Casrouge, Jérémie Decalf, et al. · Journal of Clinical Investigation · 193
Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone
2007 · Emmanuelle Coutanceau, Jeremie Decalf, et al. · The Journal of Experimental Medicine · 139
PDF
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 · Jérémie Decalf, Sandrine Fernandes, et al. · The Journal of Experimental Medicine · 131
PDF
OatA, a Peptidoglycan O-Acetyltransferase Involved in Listeria monocytogenes Immune Escape, Is Critical for Virulence
2011 · Camille Aubry, Céline Goulard, et al. · The Journal of Infectious Diseases · 126
PDF
New tools for pathology: a user's review of a highly multiplexed method for in situ analysis of protein and RNA expression in tissue
2018 · Jérémie Decalf, Matthew L Albert, et al. · The Journal of Pathology · 105
PDF
Cutting Edge: Adaptive Versus Innate Receptor Signals Selectively Control the Pool Sizes of Murine IFN-γ– or IL-17–Producing γδ T Cells upon Infection
2010 · Julie C Ribot, Miguel Chaves-Ferreira, et al. · The Journal of Immunology · 103
PDF
Immunosuppressive Signature of CutaneousMycobacterium ulceransInfection in the Peripheral Blood of Patients with Buruli Ulcer Disease
2009 · Richard Phillips, Fred S. Sarfo, et al. · The Journal of Infectious Diseases · 92
Dynamics of HIV-Containing Compartments in Macrophages Reveal Sequestration of Virions and Transient Surface Connections
2013 · Raphaël Gaudin, Stefano Berre, et al. · PLoS ONE · 81
PDF
Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents
2017 · Caroline Pereira Bittencourt Passaes, Timothée Bruel, et al. · Journal of Virology · 78
PDF
Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection
2008 · Bérangère Neveu, Emilie Debeaupuis, et al. · Hepatology · 66
PDF
Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages
2017 · Jérémie Decalf, Marion Desdouits, et al. · Journal of Virology · 58
Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post‐translational modification: prospective placebo‐controlled clinical studies
2016 · Jérémie Decalf, Kristin V Tarbell, et al. · EMBO Molecular Medicine · 53
PDF
Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy
2015 · Eric G. Meissner, Jérémie Decalf, et al. · PLoS ONE · 33
PDF
Plasmacytoid dendritic cells move down on the list of suspects: In search of the immune pathogenesis of chronic hepatitis C
2008 · Matthew L. Albert, Jérémie Decalf, et al. · Journal of Hepatology · 29
PDF
Establishment of Murine Gammaherpesvirus Latency in B Cells Is Not a Stochastic Event
2014 · Jérémie Decalf, Cristina Godinho-Silva, et al. · PLoS Pathogens · 20
PDF
The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis
2013 · Darragh Duffy, Rasha Mamdouh, et al. · Hepatology · 20
PDF
Differential levels of IFNα subtypes in autoimmunity and viral infection
2021 · Vincent Bondet, Mathieu P. Rodero, et al. · Cytokine · 17
PDF
Multimarker risk stratification approach at multiple sclerosis onset
2017 · Lidia Fernández-Paredes, Armanda Casrouge, et al. · Clinical Immunology · 13
Fibroblastic FLT3L supports lymph node dendritic cells in the interfollicular niche
2025 · Sunny Z. Wu, Ryan S. Lane, et al. · Nature Immunology · 6
Abstract 2089: Highly multiplexed analysis of immune cell subsets in non-small cell lung cancer: validation of protein and RNA analysis by the Nanostring Digital Spatial Profiling (DSP) platform
2018 · James Ziai, Patrick Caplazi, et al. · Cancer Research · 6
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinations
2025 · Jérémie Decalf, Evangeline Toy, et al. · EBioMedicine · 5
Nonclinical pharmacokinetics, pharmacodynamics and safety assessment of a FLT3L-Fc molecule for cancer immunotherapy
2024 · Kai Connie Wu, Adeyemi O. Adedeji, et al. · Toxicology and Applied Pharmacology · 5
Comment on “NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis”
2016 · Jérémie Decalf, Rosa Barreira da Silva, et al. · Science Translational Medicine · 5
A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule
2024 · Iraj Hosseini, Brett Fleisher, et al. · Pharmaceutics · 4
Works count: 41
Citation count: 1,788
H-index: 17
I10-index: 19
Year
Topic
Type